BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1275554)

  • 1. [Cellular immunity in melanomalignome (author's transl)].
    Fritz J; Grond K; Tilz GP
    Arch Dermatol Res (1975); 1976 Apr; 255(2):203-9. PubMed ID: 1275554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of autologous serum on leucocyte-migration-inhibition-test in melanomalignoma (author's transl)].
    Fritz J; Grond K
    Arch Dermatol Res (1975); 1977 Apr; 258(2):121-6. PubMed ID: 326202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
    Mitchell MS; Nordlund JJ; Lerner AB
    J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
    [No Abstract]   [Full Text] [Related]  

  • 4. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic mechanisms in malignant melanoma of the skin.
    Cochran AJ
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):385-8. PubMed ID: 347641
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.
    Cochran AJ; Thomas CE; Spilg WG; Grant RM; Cameron-Mowat DE; Mackie RM; Lindop G
    Yale J Biol Med; 1973 Dec; 46(5):650-4. PubMed ID: 4779137
    [No Abstract]   [Full Text] [Related]  

  • 9. Melanoma specific protein: occurrence in the urine of patients with halo naevus and vitiligo.
    Cooke KB; Bennett C; Staughton RC
    Br J Dermatol; 1978 Jun; 98(6):663-8. PubMed ID: 678452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 11. Human malignant melanoma antigenic properties of phenol water extracts.
    Suter L; Tilkorn H; Kövary PM
    Arch Dermatol Res; 1979 Feb; 264(1):37-47. PubMed ID: 443860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo and malignant melanoma: a significant association?
    Gregor RT
    S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
    Hellström I; Warner GA; Hellström KE; Sjögren HO
    Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
    [No Abstract]   [Full Text] [Related]  

  • 15. Epithelial membrane antigen staining of melanocytic nevi.
    Cramer SF
    Hum Pathol; 1990 Jan; 21(1):121-2. PubMed ID: 2295503
    [No Abstract]   [Full Text] [Related]  

  • 16. The halo naevus and malignant melanoma.
    Lancet; 1973 May; 1(7810):982. PubMed ID: 4121601
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma.
    Char DH; Jerome L; McCoy JL; Herberman RB
    Am J Ophthalmol; 1975 May; 79(5):812-6. PubMed ID: 1146943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological associations of the halo naevus with cutaneous malignant melanoma.
    Copeman PW; Lewis MG; Phillips TM; Elliott PG
    Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated immunity in malignant melanoma.
    Cochran AJ; Jehn UW; Gothoskar BP
    Lancet; 1972 Jun; 1(7764):1340-1. PubMed ID: 4113434
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.